Please login to the form below

Not currently logged in

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Regulatory

Novartis gets EU approval for multiple sclerosis therapy Mayzent

Novartis buildingOffers subgroup of patients an important new treatment option

From: Regulatory

J&J wins another label expansion for Darzalex in Europe

Multiple myeloma treatment indicated for early use

From: Regulatory

EU grants conditional approval to Roche's lymphoma drug Polivy

RocheDrug demonstrated a 40% complete response rate in trial

From: Research

Immuno-oncology, personalised medicine continues to drive pharma sector

DNANew GlobalData survey identifies key trends impacting the industry


Pharmaceutical Market Europe - January 2020

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Iona Everson

Have your say...

Biogen just can’t quit Alzheimer’s, licensing another drug from Pfizer

Snaps up clinical-stage candidate for $75m upfront


'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

20/20 vision

Predicting the year ahead for healthcare communications

2020 vision

Featured jobs

Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...